Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pedro M Machado

Showing results (31-40 of 227) with videos related to

Pageof 23
Sort By:
Expert Opinion on Biological Therapy|April 24, 2018
Biologics for treating axial spondyloarthritisAlexis Jones, Coziana Ciurtin, Mediola Ismajli, et al.
Annals of the Rheumatic Diseases|August 16, 2020
COVID-19 Global Rheumatology Alliance Registry, anti-IL-6 therapy, shared decision-making and patient outcomes. Response to: 'Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco <i>et al</i>. Compassionate use of tocilizumab in severe COVID-19 with hyperinflammation prior to advent of clinical trials - a real-world district general hospital experience' by Khan <i>et al,</i> 'Comment on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 global rheumatology alliance physician-reported registry' by Gianfrancesco M <i>et al'</i> by Andreica <i>et al</i> and 'COVID-19 outcomes in patients with systemic autoimmune diseases treated with immunomodulatory drugs' by Ansarin <i>et al</i>Milena Gianfrancesco, Kimme L Hyrich, Jinoos Yazdany, et al.
Frontiers in Neurology|May 14, 2023
Imaging biomarkers in the idiopathic inflammatory myopathiesAdeel S Zubair, Sharfaraz Salam, Mazen M Dimachkie, et al.
RMD Open|October 16, 2020
Determining factors related to impaired spinal and hip mobility in patients with axial spondyloarthritis: longitudinal results from the DESIR cohortPedro D Carvalho, Adeline Ruyssen-Witrand, Joao Fonseca, et al.
Annals of the Rheumatic Diseases|October 15, 2015
MRI vertebral corner inflammation followed by fat deposition is the strongest contributor to the development of new bone at the same vertebral corner: a multilevel longitudinal analysis in patients with ankylosing spondylitisPedro M Machado, Xenofon Baraliakos, Désirée van der Heijde, et al.
Annals of the Rheumatic Diseases|July 2, 2020
Response to: 'Glucocorticoid-induced relapse of COVID-19 in a patient with sarcoidosis' by Györfi <i>et al</i>Milena Gianfrancesco, Kimme L Hyrich, Jinoos Yazdany, et al.
The Lancet. Rheumatology|January 24, 2024
Idiopathic inflammatory myopathies: current insights and future frontiersCaoilfhionn M Connolly, Latika Gupta, Manabu Fujimoto, et al.
RMD Open|August 21, 2023
Efficacy of non-pharmacological interventions: a systematic review informing the 2023 EULAR recommendations for the management of fatigue in people with inflammatory rheumatic and musculoskeletal diseasesEduardo José Ferreira Santos, Bayram Farisogullari, Emma Dures, et al.
RMD Open|December 6, 2023
Efficacy of pharmacological interventions: a systematic review informing the 2023 EULAR recommendations for the management of fatigue in people with inflammatory rheumatic and musculoskeletal diseasesBayram Farisogullari, Eduardo José Ferreira Santos, Emma Dures, et al.
Clinical and Experimental Rheumatology|February 19, 2024
Imaging swallowing function and the mechanisms driving dysphagia in inclusion body myositisSharfaraz Salam, Jodi Allen, Mazen M Dimachkie, et al.
Pageof 23

Showing results (31-40 of 227) with videos related to

Sort By:
Pageof 23
Expert Opinion on Biological Therapy|April 24, 2018
Biologics for treating axial spondyloarthritisAlexis Jones, Coziana Ciurtin, Mediola Ismajli, et al.
Annals of the Rheumatic Diseases|August 16, 2020
COVID-19 Global Rheumatology Alliance Registry, anti-IL-6 therapy, shared decision-making and patient outcomes. Response to: 'Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco <i>et al</i>. Compassionate use of tocilizumab in severe COVID-19 with hyperinflammation prior to advent of clinical trials - a real-world district general hospital experience' by Khan <i>et al,</i> 'Comment on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 global rheumatology alliance physician-reported registry' by Gianfrancesco M <i>et al'</i> by Andreica <i>et al</i> and 'COVID-19 outcomes in patients with systemic autoimmune diseases treated with immunomodulatory drugs' by Ansarin <i>et al</i>Milena Gianfrancesco, Kimme L Hyrich, Jinoos Yazdany, et al.
Frontiers in Neurology|May 14, 2023
Imaging biomarkers in the idiopathic inflammatory myopathiesAdeel S Zubair, Sharfaraz Salam, Mazen M Dimachkie, et al.
RMD Open|October 16, 2020
Determining factors related to impaired spinal and hip mobility in patients with axial spondyloarthritis: longitudinal results from the DESIR cohortPedro D Carvalho, Adeline Ruyssen-Witrand, Joao Fonseca, et al.
Annals of the Rheumatic Diseases|October 15, 2015
MRI vertebral corner inflammation followed by fat deposition is the strongest contributor to the development of new bone at the same vertebral corner: a multilevel longitudinal analysis in patients with ankylosing spondylitisPedro M Machado, Xenofon Baraliakos, Désirée van der Heijde, et al.
Annals of the Rheumatic Diseases|July 2, 2020
Response to: 'Glucocorticoid-induced relapse of COVID-19 in a patient with sarcoidosis' by Györfi <i>et al</i>Milena Gianfrancesco, Kimme L Hyrich, Jinoos Yazdany, et al.
The Lancet. Rheumatology|January 24, 2024
Idiopathic inflammatory myopathies: current insights and future frontiersCaoilfhionn M Connolly, Latika Gupta, Manabu Fujimoto, et al.
RMD Open|August 21, 2023
Efficacy of non-pharmacological interventions: a systematic review informing the 2023 EULAR recommendations for the management of fatigue in people with inflammatory rheumatic and musculoskeletal diseasesEduardo José Ferreira Santos, Bayram Farisogullari, Emma Dures, et al.
RMD Open|December 6, 2023
Efficacy of pharmacological interventions: a systematic review informing the 2023 EULAR recommendations for the management of fatigue in people with inflammatory rheumatic and musculoskeletal diseasesBayram Farisogullari, Eduardo José Ferreira Santos, Emma Dures, et al.
Clinical and Experimental Rheumatology|February 19, 2024
Imaging swallowing function and the mechanisms driving dysphagia in inclusion body myositisSharfaraz Salam, Jodi Allen, Mazen M Dimachkie, et al.
Pageof 23